Showing results (501-510 of 531) with videos related to
Sort By:
Pageof 54
Cellular and Molecular Gastroenterology and Hepatology|December 11, 2023
IGF2BP1/IMP1 Deletion Enhances a Facultative Stem Cell State via Regulation of MAP1LC3BLouis R Parham, Patrick A Williams, Kay Katada, et al.Lancet (London, England)|January 23, 2022
An educational programme in neonatal intensive care units (SEPREVEN): a stepped-wedge, cluster-randomised controlled trialLaurence Caeymaex, Dominique Astruc, Valérie Biran, et al.Scientific Reports|August 26, 2017
Genome-wide association study of bronchopulmonary dysplasia: a potential role for variants near the CRP geneMari Mahlman, Minna K Karjalainen, Johanna M Huusko, et al.Hepatology International|October 31, 2020
Entecavir combining Chinese herbal medicine for HBeAg-positive chronic hepatitis B patients: a randomized, controlled trialXiaoke Li, Daqiao Zhou, Xiaoling Chi, et al.Cancer Research|May 19, 2007
Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse modelsHongbin Ji, Zhenxiong Wang, Samanthi A Perera, et al.Cancer Cell|May 30, 2006
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapiesHongbin Ji, Danan Li, Liang Chen, et al.Nature|March 23, 2023
RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancerAmina Jbara, Kuan-Ting Lin, Chani Stossel, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|February 28, 2023
Intestinal epithelial autophagy is required for the regenerative benefit of calorie restrictionPatrick A Williams, Kaitlyn E Naughton, Lauren A Simon, et al.Nature Medicine|August 29, 2022
Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphomaNathalie Scholler, Regis Perbost, Frederick L Locke, et al.Trials|August 14, 2020
Chinese herbal medicine combined with entecavir to reduce the off-therapy recurrence risk in HBeAg-positive chronic hepatitis B patients: a multicener, double-blind, randomized controlled trial in ChinaXiaoke Li, Ludan Zhang, Mei Qiu, et al.Pageof 54